NO20010659D0 - Vannlöselige fördroger av hindrede alkoholer eller fenoler - Google Patents

Vannlöselige fördroger av hindrede alkoholer eller fenoler

Info

Publication number: NO20010659D0
Authority: NO; Norway
Prior art keywords: water; phenols; soluble drugs; hindered alcohols; hindered
Prior art date: 1998-08-07

Application number

NO20010659A

Other languages

English (en)

Other versions

NO20010659L (no

NO330357B1 (no

Inventor

Stella J Valentino

Jan J Zygmunt

Ingrid Gunda Georg

Muhammed S Safadi

Original Assignee

Univ Kansas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-07

Filing date

2001-02-07

Publication date

2001-02-07

2001-02-07 Application filed by Univ Kansas filed Critical Univ Kansas

2001-02-07 Publication of NO20010659D0 publication Critical patent/NO20010659D0/no

2001-04-06 Publication of NO20010659L publication Critical patent/NO20010659L/no

2011-04-04 Publication of NO330357B1 publication Critical patent/NO330357B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Anesthesiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Pyrane Compounds (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Steroid Compounds (AREA)
Compounds Of Unknown Constitution (AREA)

NO20010659A 1998-08-07 2001-02-07 Vannloselige, fenolinneholdende forbindelser og fremstilling derav, farmasoytisk sammensetning inneholdende disse, og anvendelse av forbindelsene i fremstilling av medikamenter NO330357B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/131,385 US6204257B1 (en)	1998-08-07	1998-08-07	Water soluble prodrugs of hindered alcohols
PCT/US1999/017779 WO2000008033A1 (en)	1998-08-07	1999-08-06	Water soluble prodrugs of hindered alcohols or phenols

Publications (3)

Publication Number	Publication Date
NO20010659D0 true NO20010659D0 (no)	2001-02-07
NO20010659L NO20010659L (no)	2001-04-06
NO330357B1 NO330357B1 (no)	2011-04-04

Family

ID=22449234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20010659A NO330357B1 (no)	1998-08-07	2001-02-07	Vannloselige, fenolinneholdende forbindelser og fremstilling derav, farmasoytisk sammensetning inneholdende disse, og anvendelse av forbindelsene i fremstilling av medikamenter

Country Status (27)

Country	Link
US (4)	US6204257B1 (no)
EP (2)	EP1683803A1 (no)
JP (1)	JP4554081B2 (no)
KR (1)	KR100662799B1 (no)
CN (2)	CN1680402A (no)
AT (1)	ATE319723T1 (no)
AU (1)	AU769755B2 (no)
BR (1)	BR9912853A (no)
CA (1)	CA2339834C (no)
CY (1)	CY1105043T1 (no)
CZ (1)	CZ304020B6 (no)
DE (1)	DE69930269T2 (no)
DK (1)	DK1102776T3 (no)
ES (1)	ES2268876T3 (no)
HK (1)	HK1047939B (no)
HU (1)	HU229401B1 (no)
IL (1)	IL141316A (no)
MX (1)	MXPA01001431A (no)
NO (1)	NO330357B1 (no)
NZ (1)	NZ509795A (no)
PL (1)	PL198141B1 (no)
PT (1)	PT1102776E (no)
RU (1)	RU2235727C2 (no)
TR (1)	TR200100772T2 (no)
UA (1)	UA73479C2 (no)
WO (1)	WO2000008033A1 (no)
ZA (1)	ZA200101039B (no)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
US6204257B1 (en) *	1998-08-07	2001-03-20	Universtiy Of Kansas	Water soluble prodrugs of hindered alcohols
EP1105096B1 (en)	1998-08-19	2003-10-29	Skyepharma Canada Inc.	Injectable aqueous dispersions of propofol
US6362172B2 (en) *	2000-01-20	2002-03-26	Bristol-Myers Squibb Company	Water soluble prodrugs of azole compounds
US6362234B1 (en) *	2000-08-15	2002-03-26	Vyrex Corporation	Water-soluble prodrugs of propofol for treatment of migrane
US6448401B1 (en) *	2000-11-20	2002-09-10	Bristol-Myers Squibb Company	Process for water soluble azole compounds
ES2256450T3 (es) *	2001-04-20	2006-07-16	Debiopharm S.A.	Ciclosporina modificada utilizable como profarmaco y su uso.
US6815555B2 (en)	2001-09-26	2004-11-09	Theravance, Inc.	Substituted phenol compounds useful for anesthesia and sedation
KR101016969B1 (ko) *	2001-12-21	2011-02-25	에이자이 아이엔씨.	알콜 및 페놀의 수용성 포스포노옥시메틸 유도체를제조하는 방법
BR0215303A (pt) *	2001-12-28	2005-04-05	Guilford Pharm Inc	Formulações farmacêuticas de base aquosa de pró-drogas solúveis em água de propofol
KR20070087004A (ko) *	2002-04-08	2007-08-27	엠쥐아이 쥐피, 아이엔씨.	프로포폴의 수용성 프로드럭을 함유하는 약제학적 조성물및 그것을 투여하는 방법
ITRM20020306A1 (it)	2002-05-31	2003-12-01	Sigma Tau Ind Farmaceuti	Esteri in posizione 20 di camptotecine.
AU2002950713A0 (en)	2002-08-09	2002-09-12	Vital Health Sciences Pty Ltd	Carrier
ZA200504940B (en) *	2003-01-28	2006-09-27	Xenoport Inc	Amino acid derived prodrugs of propofol, compositions and uses thereof
CA2518265A1 (en)	2003-03-17	2004-09-30	Albany Molecular Research, Inc.	Novel cyclosporins
AU2003901815A0 (en) *	2003-04-15	2003-05-01	Vital Health Sciences Pty Ltd	Phosphate derivatives
WO2005023204A2 (en) *	2003-09-09	2005-03-17	Xenoport, Inc.	Aromatic prodrugs of propofol, compositions and uses thereof
CN1882548A (zh) *	2003-10-24	2006-12-20	奥斯佩克斯制药公司	2,6－二异丙基苯酚的pH敏感性前药
US7834043B2 (en) *	2003-12-11	2010-11-16	Abbott Laboratories	HIV protease inhibiting compounds
US20070202158A1 (en) *	2003-12-17	2007-08-30	Mgi Gp, Inc.	Methods Of Administering Water-Soluble Prodrugs Of Propofol For Extended Sedation
US8129346B2 (en)	2004-04-15	2012-03-06	Onyx Therapeutics, Inc.	Compounds for enzyme inhibition
US7232818B2 (en) *	2004-04-15	2007-06-19	Proteolix, Inc.	Compounds for enzyme inhibition
US8198270B2 (en) *	2004-04-15	2012-06-12	Onyx Therapeutics, Inc.	Compounds for proteasome enzyme inhibition
CA2565407A1 (en) *	2004-05-10	2005-11-24	Proteolix, Inc.	Compounds for enzyme inhibition
US20050256324A1 (en) *	2004-05-10	2005-11-17	Proteolix, Inc.	Synthesis of amino acid keto-epoxides
EP2336138A3 (en) *	2004-07-06	2011-11-16	Abbott Laboratories	Prodrugs of HIV protease inhibitors
US7241807B2 (en) *	2004-07-12	2007-07-10	Xenoport, Inc.	Prodrugs of propofol, compositions and uses thereof
PT1781596E (pt) *	2004-07-12	2009-01-12	Xenoport Inc	Pró-fármacos de propofol derivados de aminoácidos, composições e utilizações dos mesmos
US20060014677A1 (en) *	2004-07-19	2006-01-19	Isotechnika International Inc.	Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
EP2266622A3 (en) *	2004-08-26	2012-06-20	Piramal Life Sciences Limited	Prodrugs containing novel bio-cleavable linkers
WO2006033911A2 (en) *	2004-09-17	2006-03-30	Mgi Gp, Inc.	Methods of administering water-soluble prodrugs of propofol
JP2008514701A (ja)	2004-09-29	2008-05-08	エーエムアールテクノロジーインコーポレイテッド	シクロスポリンアルキン類似体およびそれらの薬学的使用
US7511013B2 (en)	2004-09-29	2009-03-31	Amr Technology, Inc.	Cyclosporin analogues and their pharmaceutical uses
WO2006041631A2 (en)	2004-10-06	2006-04-20	Amr Technology, Inc.	Novel cyclosporin alkynes and their utility as pharmaceutical agents
ATE456552T1 (de) *	2004-12-23	2010-02-15	Xenoport Inc	Von serinaminosäure abgeleitete prodrugs von propofol, zusammensetzungen, anwendungen und kristalline formen davon
EP2548581A3 (en)	2005-06-17	2013-02-20	Vital Health Sciences Pty Ltd.	A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
WO2007008869A1 (en) *	2005-07-12	2007-01-18	Mgi Gp, Inc.	Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation
US20080234229A1 (en) *	2005-08-18	2008-09-25	Auspex Pharmaceuticals, Inc.	Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
ES2441608T3 (es)	2005-08-18	2014-02-05	Zimmer Gmbh	Artículos de polietileno de peso molecular ultra-alto y métodos para formar artículos de polietileno de peso molecular ulra-alto
WO2007028104A2 (en) *	2005-09-02	2007-03-08	Auspex Pharmaceuticals, Inc.	Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
CN101282979B (zh) *	2005-09-13	2011-09-21	卫材R&D管理有限公司	稳定性被改善的含有磷酸氯甲酯衍生物的组合物及其制备方法
KR101434522B1 (ko) *	2005-11-09	2014-08-26	오닉스 세라퓨틱스, 인크.	효소 저해를 위한 화합물
US7691852B2 (en) *	2006-06-19	2010-04-06	Onyx Therapeutics, Inc.	Compounds for enzyme inhibition
CN101583271B (zh) *	2006-10-05	2013-07-17	卫材公司	丙泊酚水溶性前药的水基药物制剂
US20080161400A1 (en) *	2006-10-26	2008-07-03	Xenoport, Inc.	Use of forms of propofol for treating diseases associated with oxidative stress
US8664290B2 (en)	2007-04-10	2014-03-04	Zimmer, Inc.	Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
ES2378721T3 (es)	2007-04-10	2012-04-17	Zimmer, Inc.	Polietileno reticulado de peso molecular ultra alto estabilizado por antioxidantes para aplicaciones en dispositivos médicos
PL2146946T3 (pl)	2007-05-09	2011-04-29	Pharmacofore Inc	(-)-Stereoizomer 2,6-di-sec-butylofenolu i jego analogi
CA2685813A1 (en)	2007-05-09	2008-11-20	Pharmacofore, Inc.	Therapeutic compounds
US20090005444A1 (en) *	2007-06-21	2009-01-01	Xenoport, Inc.	Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus
FI20070574A0 (fi) *	2007-07-30	2007-07-30	Kuopion Yliopisto	Vesiliukoinen propofolin etylideenifosfaatti-aihiolääke
US8427384B2 (en)	2007-09-13	2013-04-23	Aerosat Corporation	Communication system with broadband antenna
CN101842938B (zh) *	2007-09-13	2014-11-05	天文电子学爱罗莎特股份有限公司	有宽带天线的通信系统
WO2009036322A1 (en) *	2007-09-14	2009-03-19	Xenoport, Inc.	Use of propofol prodrugs for treating neuropathic pain
US20090075947A1 (en) *	2007-09-17	2009-03-19	Protia, Llc	Deuterium-enriched fospropofol
RS54847B2 (sr)	2007-10-04	2019-09-30	Onyx Therapeutics Inc	Inhibitori kristalne peptid epoksi keton proteaze i sinteza aminokiselinskih keto-epoksida
US20090098209A1 (en) *	2007-10-15	2009-04-16	University Of Kansas	Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration
WO2009120162A1 (ru) *	2008-03-25	2009-10-01	Zhukovskij Oleg Igorevich	Субстанция "ua' orion"
JP5519645B2 (ja)	2008-05-20	2014-06-11	ニューロジェシックス，インコーポレイテッド	カーボネートプロドラッグおよびそれを使用する方法
BRPI0912326A2 (pt)	2008-05-20	2015-10-06	Neurogesx Inc	análogos de acetaminofeno hidrossolúveis
WO2010047737A2 (en)	2008-09-02	2010-04-29	Micurx Pharmaceuticals, Inc.	Antimicrobial indoline compounds for treatment of bacterial infections
JP5675629B2 (ja)	2008-10-21	2015-02-25	オニキスセラピューティクス，インク．ＯｎｙｘＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	ペプチドエポキシケトンを用いた併用療法
CN101798302B (zh)	2009-02-06	2014-11-05	上海盟科药业有限公司	抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
AR075899A1 (es)	2009-03-20	2011-05-04	Onyx Therapeutics Inc	Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
CN101845057B (zh) *	2009-03-27	2013-10-23	四川大学	取代苯酚的甲缩醛磷酸盐麻醉镇静药用化合物及制备方法
GB0905834D0 (en)	2009-04-03	2009-05-20	Seps Pharma Nv	Phosphonyl-containing phenolic derivatives useful as medicaments
US9150600B2 (en)	2009-05-07	2015-10-06	Regents Of The University Of Minnesota	Triptolide prodrugs
PL2427467T3 (pl) *	2009-05-07	2016-04-29	Univ Minnesota	Proleki tryptolidu
CN101648973B (zh) *	2009-09-03	2012-05-30	漆又毛	水溶性紫杉烷及制备方法
JP5919196B2 (ja)	2009-11-13	2016-05-18	オニキスセラピューティクス，インク．ＯｎｙｘＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	転移抑制のためのペプチドエポキシケトンの使用
AU2011213557B2 (en)	2010-02-05	2015-05-07	Phosphagenics Limited	Carrier comprising non-neutralised tocopheryl phosphate
CN102153607B (zh) *	2010-02-11	2015-07-15	湖南方盛华美医药科技有限公司	水溶性喜树碱衍生物及包含其的药物组合物
MA34133B1 (fr)	2010-03-01	2013-04-03	Onyx Therapeutics Inc	Composes pour inhibiteurs de l'immunoproteasome
US8652511B2 (en)	2010-03-30	2014-02-18	Phosphagenics Limited	Transdermal delivery patch
WO2011136905A2 (en)	2010-04-07	2011-11-03	Onyx Therapeutics, Inc.	Crystalline peptide epoxyketone immunoproteasome inhibitor
RU2426541C1 (ru) *	2010-05-11	2011-08-20	Государственное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию"	Способ профилактики послеоперационной тошноты и рвоты у детей в отоларингологической хирургии
US8399535B2 (en) *	2010-06-10	2013-03-19	Zimmer, Inc.	Polymer [[s]] compositions including an antioxidant
US20120065170A1 (en)	2010-09-10	2012-03-15	Micurx Pharmaceuticals, Inc.	Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
HRP20160478T1 (hr) *	2010-12-02	2016-07-01	The University Of Kansas	Prolijekovi 6-cikloheksil-1-hidroksi-4-metilpiridin-2-(1h)-ona i njihovi derivati
US9561243B2 (en)	2011-03-15	2017-02-07	Phosphagenics Limited	Composition comprising non-neutralised tocol phosphate and a vitamin A compound
ITMI20110580A1 (it) *	2011-04-08	2012-10-09	Chemelectiva S R L	Iintermedi utili per la preparazione di fospropofol e processo per la loro preparazione
UY34072A (es)	2011-05-17	2013-01-03	Novartis Ag	Derivados sustituidos de indol
JP6029670B2 (ja)	2011-09-22	2016-11-24	アコーダセラピューティクス、インク．	アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法
CN102516258B (zh) *	2011-11-11	2014-06-25	正大天晴药业集团股份有限公司	水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用
CN102382133B (zh) *	2011-12-02	2016-03-23	陕西合成药业股份有限公司	一种磷丙泊酚钠的制备及纯化方法
US20140105921A1 (en)	2012-07-09	2014-04-17	Onyx Therapeutics, Inc.	Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
US9580459B2 (en) *	2013-04-26	2017-02-28	Metselex, Inc.	Water-soluble ursodeoxycholic acid prodrugs
EP3052562B1 (en)	2013-10-01	2017-11-08	Zimmer, Inc.	Polymer compositions comprising one or more protected antioxidants
EP3099304B1 (en) *	2014-01-31	2024-07-17	Mayo Foundation for Medical Education and Research	Chroman derivatives and their use in the treatment of glaucoma
JP6671303B2 (ja)	2014-02-21	2020-03-25	ミクウルクファーマシューティカルズ，インコーポレイテッド	治療的投与のための水溶性ｏ−カルボニルホスホルアミダートプロドラッグ
US10184031B2 (en)	2014-03-12	2019-01-22	Zimmer, Inc.	Melt-stabilized ultra high molecular weight polyethylene and method of making the same
CA2965379A1 (en)	2014-10-21	2016-04-28	Abbvie Inc.	Carbidopa and l-dopa prodrugs and methods of use
CA2969751C (en)	2014-12-03	2020-09-22	Zimmer, Inc.	Antioxidant-infused ultra high molecular weight polyethylene
CN106674269A (zh) *	2015-11-11	2017-05-17	陕西合成药业股份有限公司	一种磷丙泊酚钠四水合物及晶型及其制备方法和用途
CN106674270A (zh) *	2015-11-11	2017-05-17	陕西合成药业股份有限公司	一种磷丙泊酚钠无水合物及晶型及其制备方法和用途
CN106674268A (zh) *	2015-11-11	2017-05-17	陕西合成药业股份有限公司	一种磷丙泊酚钠三水合物及晶型及其制备方法和用途
CN108601732A (zh)	2015-12-09	2018-09-28	磷肌酸有限公司	药物制剂
US10851123B2 (en) *	2016-02-23	2020-12-01	Concentric Analgesics, Inc.	Prodrugs of phenolic TRPV1 agonists
JP2019515908A (ja) *	2016-04-20	2019-06-13	アッヴィ・インコーポレイテッド	カルビドパ及びｌ−ドパプロドラッグ並びに使用方法
US11331271B2 (en) *	2016-05-27	2022-05-17	The Johns Hopkins University	Buccal, sublingual and intranasal delivery of fospropofol
WO2018017518A2 (en)	2016-07-21	2018-01-25	Astronics Aerosat Corporation	Multi-channel communications antenna
IL267006B2 (en)	2016-12-21	2024-11-01	Phosphagenics Ltd	Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof
US10992052B2 (en)	2017-08-28	2021-04-27	Astronics Aerosat Corporation	Dielectric lens for antenna system
US10174138B1 (en) *	2018-01-25	2019-01-08	University Of Massachusetts	Method for forming highly reactive olefin functional polymers
AU2019379806B2 (en)	2018-11-15	2025-08-14	Abbvie Inc.	Pharmaceutical formulations for subcutaneous administration
CN109456360B (zh) *	2018-12-17	2021-05-14	河南中医药大学	一种磷丙泊酚钠的制备方法
WO2020156189A1 (zh) *	2019-01-30	2020-08-06	四川科伦博泰生物医药股份有限公司	喜树碱衍生物及其水溶性前药、包含其的药物组合物及其制备方法和用途
US11439653B1 (en)	2021-03-30	2022-09-13	Epalex Corporation	Fospropofol formulations
US11478490B1 (en)	2021-03-30	2022-10-25	Epalex Corporation	Fospropofol formulations
US11547714B2 (en)	2020-02-05	2023-01-10	Epalex Corporation	Fospropofol salts, methods and compositions
US11628178B2 (en)	2019-03-26	2023-04-18	Epalex Corporation	Fospropofol methods and compositions
CA3159771A1 (en)	2019-12-12	2021-06-17	Thurein M. Htoo	Controlled-delivery cromakalim prodrugs
WO2021228150A1 (zh) *	2020-05-13	2021-11-18	成都百裕制药股份有限公司	大麻素衍生物及其制备方法和在医药上的应用
AU2022253902A1 (en)	2021-04-10	2023-11-02	Genmab A/S	Folr1 binding agents, conjugates thereof and methods of using the same
TW202308699A (zh)	2021-04-23	2023-03-01	美商普方生物製藥美國公司	Ｃｄ７０結合劑、其結合物及其使用方法
TW202320857A (zh)	2021-07-06	2023-06-01	美商普方生物製藥美國公司	連接子、藥物連接子及其結合物及其使用方法
AR133955A1 (es)	2023-09-26	2025-11-19	Profoundbio Us Co	Agentes de unión a ptk7, conjugados de éstos y métodos de uso de los mismos
US20250296992A1 (en)	2024-01-10	2025-09-25	Genmab A/S	Slitrk6 binding agents, conjugates thereof and methods of using the same
US20250381289A1 (en)	2024-02-29	2025-12-18	Genmab A/S	Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the same

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2829151A (en)	1952-11-03	1958-04-01	Dow Chemical Co	Chlorotoloxy-ethyl phosphates
US3271314A (en)	1958-12-04	1966-09-06	Ethyl Corp	2, 6-diisopropylphenol
GB1146173A (en)	1966-06-18	1969-03-19	Geigy Uk Ltd	Production of triaryl phosphates
US3723578A (en)	1970-10-13	1973-03-27	Gaf Corp	Phosphate esters of ethers of thiol substituted phenols
US4171272A (en)	1977-12-02	1979-10-16	Fmc Corporation	Turbine lubricant
FR2601259B1 (fr)	1986-07-11	1990-06-22	Rhone Poulenc Chimie	Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives.
US5106742A (en)	1987-03-31	1992-04-21	Wall Monroe E	Camptothecin analogs as potent inhibitors of topoisomerase I
US5244903A (en)	1987-03-31	1993-09-14	Research Triangle Institute	Camptothecin analogs as potent inhibitors of topoisomerase I
US5364858A (en)	1987-03-31	1994-11-15	Research Triangle Institute	Camptothecin analogs as potent inhibitors of topoisomerase I
US5053512A (en)	1987-04-14	1991-10-01	Research Triangle Institute	Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US4894456A (en)	1987-03-31	1990-01-16	Research Triangle Institute	Synthesis of camptothecin and analogs thereof
US5122526A (en)	1987-03-31	1992-06-16	Research Triangle Institute	Camptothecin and analogs thereof and pharmaceutical compositions and method using them
US4981968A (en)	1987-03-31	1991-01-01	Research Triangle Institute	Synthesis of camptothecin and analogs thereof
US5180722A (en)	1987-04-14	1993-01-19	Research Triangle Institute	10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
US5049668A (en)	1989-09-15	1991-09-17	Research Triangle Institute	10,11-methylenedioxy-20(RS)-camptothecin analogs
US5122606A (en)	1987-04-14	1992-06-16	Research Triangle Institute	10,11-methylenedioxy camptothecins
MY103951A (en)	1988-01-12	1993-10-30	Kao Corp	Detergent composition
CA2014539C (en)	1989-04-17	2000-07-25	Shinichiro Umeda	Water borne metallic coating composition
US5091211A (en)	1989-08-17	1992-02-25	Lord Corporation	Coating method utilizing phosphoric acid esters
JPH03209414A (ja)	1990-01-12	1991-09-12	Nikon Corp	焦点調節装置
AU660918B2 (en)	1990-10-17	1995-07-13	Arysta Lifescience Corporation	Method and composition for enhancing uptake and transport of bioactive agents in plants
US5646176A (en)	1992-12-24	1997-07-08	Bristol-Myers Squibb Company	Phosphonooxymethyl ethers of taxane derivatives
MX9308012A (es)	1992-12-24	1994-08-31	Bristol Myers Squibb Co	Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
CA2129288C (en)	1993-08-17	2000-05-16	Jerzy Golik	Phosphonooxymethyl esters of taxane derivatives
US5731356A (en) *	1994-03-22	1998-03-24	Zeneca Limited	Pharmaceutical compositions of propofol and edetate
US5786344A (en) *	1994-07-05	1998-07-28	Arch Development Corporation	Camptothecin drug combinations and methods with reduced side effects
US5646159A (en)	1994-07-20	1997-07-08	Research Triangle Institute	Water-soluble esters of camptothecin compounds
IT1270093B (it)	1994-09-28	1997-04-28	Zambon Spa	Processo per la purificazione di 2,6-diisopropilfenolo
TW354293B (en)	1995-06-06	1999-03-11	Bristol Myers Squibb Co	Prodrugs of paclitaxel derivatives
US5804682A (en)	1995-11-29	1998-09-08	Henkel Corporation	Aqueous dispersions of polyamides
US5637625A (en)	1996-03-19	1997-06-10	Research Triangle Pharmaceuticals Ltd.	Propofol microdroplet formulations
US5746973A (en)	1996-07-10	1998-05-05	Naraghi; Ali	Method for reducing odorant depletion
WO1999038873A1 (en) *	1998-01-29	1999-08-05	Bristol-Myers Squibb Company	Phosphate derivatives of diaryl 1,3,4-oxadiazolone
US6204257B1 (en) *	1998-08-07	2001-03-20	Universtiy Of Kansas	Water soluble prodrugs of hindered alcohols

1998
- 1998-08-07 US US09/131,385 patent/US6204257B1/en not_active Expired - Lifetime
1999
- 1999-06-08 UA UA2001031520A patent/UA73479C2/uk unknown
- 1999-08-06 WO PCT/US1999/017779 patent/WO2000008033A1/en not_active Ceased
- 1999-08-06 HU HU0200317A patent/HU229401B1/hu not_active IP Right Cessation
- 1999-08-06 EP EP06004146A patent/EP1683803A1/en not_active Withdrawn
- 1999-08-06 PL PL347211A patent/PL198141B1/pl unknown
- 1999-08-06 JP JP2000563666A patent/JP4554081B2/ja not_active Expired - Fee Related
- 1999-08-06 PT PT99939030T patent/PT1102776E/pt unknown
- 1999-08-06 TR TR2001/00772T patent/TR200100772T2/xx unknown
- 1999-08-06 RU RU2001106614/04A patent/RU2235727C2/ru not_active IP Right Cessation
- 1999-08-06 BR BR9912853-5A patent/BR9912853A/pt not_active Application Discontinuation
- 1999-08-06 IL IL14131699A patent/IL141316A/en not_active IP Right Cessation
- 1999-08-06 ES ES99939030T patent/ES2268876T3/es not_active Expired - Lifetime
- 1999-08-06 AU AU53394/99A patent/AU769755B2/en not_active Ceased
- 1999-08-06 HK HK03100006.9A patent/HK1047939B/zh not_active IP Right Cessation
- 1999-08-06 DK DK99939030T patent/DK1102776T3/da active
- 1999-08-06 CN CNA2005100524949A patent/CN1680402A/zh active Pending
- 1999-08-06 KR KR1020017001674A patent/KR100662799B1/ko not_active Expired - Fee Related
- 1999-08-06 CZ CZ20010479A patent/CZ304020B6/cs not_active IP Right Cessation
- 1999-08-06 DE DE69930269T patent/DE69930269T2/de not_active Expired - Lifetime
- 1999-08-06 NZ NZ509795A patent/NZ509795A/en not_active IP Right Cessation
- 1999-08-06 CA CA2339834A patent/CA2339834C/en not_active Expired - Fee Related
- 1999-08-06 MX MXPA01001431A patent/MXPA01001431A/es active IP Right Grant
- 1999-08-06 AT AT99939030T patent/ATE319723T1/de active
- 1999-08-06 CN CNB998114405A patent/CN1198834C/zh not_active Expired - Fee Related
- 1999-08-06 EP EP99939030A patent/EP1102776B1/en not_active Expired - Lifetime
2000
- 2000-12-08 US US09/733,817 patent/US6451776B2/en not_active Expired - Lifetime
2001
- 2001-02-07 NO NO20010659A patent/NO330357B1/no not_active IP Right Cessation
- 2001-02-07 ZA ZA200101039A patent/ZA200101039B/en unknown
2002
- 2002-07-29 US US10/208,647 patent/US6872838B2/en not_active Expired - Fee Related
2004
- 2004-11-17 US US10/991,348 patent/US7244718B2/en not_active Expired - Fee Related
2006
- 2006-06-02 CY CY20061100710T patent/CY1105043T1/el unknown

Also Published As

Publication number	Publication date
CN1198834C (zh)	2005-04-27
KR20010079627A (ko)	2001-08-22
EP1102776B1 (en)	2006-03-08
CZ2001479A3 (cs)	2001-09-12
UA73479C2 (uk)	2005-08-15
PT1102776E (pt)	2007-02-28
HUP0200317A2 (en)	2002-06-29
CN1680402A (zh)	2005-10-12
NO20010659L (no)	2001-04-06
HK1047939B (zh)	2005-11-18
HK1047939A1 (en)	2003-03-14
TR200100772T2 (tr)	2001-12-21
PL198141B1 (pl)	2008-05-30
AU5339499A (en)	2000-02-28
EP1102776A1 (en)	2001-05-30
US6204257B1 (en)	2001-03-20
RU2235727C2 (ru)	2004-09-10
ZA200101039B (en)	2002-02-05
JP4554081B2 (ja)	2010-09-29
IL141316A0 (en)	2002-03-10
MXPA01001431A (es)	2002-11-29
US6872838B2 (en)	2005-03-29
CZ304020B6 (cs)	2013-08-28
US6451776B2 (en)	2002-09-17
CN1357000A (zh)	2002-07-03
CA2339834A1 (en)	2000-02-17
WO2000008033A1 (en)	2000-02-17
US20010025035A1 (en)	2001-09-27
HU229401B1 (en)	2013-12-30
DK1102776T3 (da)	2006-07-10
IL141316A (en)	2004-06-20
BR9912853A (pt)	2001-10-30
AU769755B2 (en)	2004-02-05
DE69930269D1 (de)	2006-05-04
NZ509795A (en)	2003-10-31
KR100662799B1 (ko)	2007-01-02
PL347211A1 (en)	2002-03-25
DE69930269T2 (de)	2006-12-07
US20050090431A1 (en)	2005-04-28
US7244718B2 (en)	2007-07-17
EP1683803A1 (en)	2006-07-26
HUP0200317A3 (en)	2004-07-28
NO330357B1 (no)	2011-04-04
CY1105043T1 (el)	2010-03-03
CA2339834C (en)	2011-01-25
JP2002522443A (ja)	2002-07-23
ES2268876T3 (es)	2007-03-16
ATE319723T1 (de)	2006-03-15
US20030176324A1 (en)	2003-09-18

Publication	Publication Date	Title
NO20010659D0 (no)	2001-02-07	Vannlöselige fördroger av hindrede alkoholer eller fenoler
ES2195970T3 (es)	2003-12-16	L-ribavirina y usos de la misma.
EP1760067A3 (en)	2007-05-30	Compounds with protected hydroxy groups
IL124593A0 (en)	1998-12-06	Substituted aryl or heteroarylamides having retinoid-like biological activity
ES2058725T3 (es)	1994-11-01	Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol.
MX9101224A (es)	1992-05-04	1-alfa hidroxi vitamina d4 novedosa e intermediarios y analogos novedosos
ATE76069T1 (de)	1992-05-15	5-nitrobenzo(de>isochinolin-1,3-dione, ihre herstellung und verwendung.
BG102215A (en)	1998-09-30	Compounds and pharmaceutical compositions containing them
AU674378B2 (en)	1996-12-19	Use of 2-amino-6-A-propylamino-4,5,6, 7-tetrahydrobenzothiazole (pramipexol) as an anti-depressantdrug
FI930977A0 (fi)	1993-03-04	Taxanderivat, deras framstaellning och onkologiska anvaendning
TR199802255T2 (xx)	1999-02-22	Eklembacakl�lar� uzakla�t�ran maddeler.
ES2161446T3 (es)	2001-12-01	Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ATE68200T1 (de)	1991-10-15	Antioxidanz-produkte.
DE69124844D1 (de)	1997-04-10	Radicicol-Derivate, ihre Herstellung und ihre Antitumorwirkung
BR9714049A (pt)	2000-05-09	Imidazopiridazinas
ES2186191T3 (es)	2003-05-01	Productos de reaccion del acido fosfonico y su uso en composiciones de recubrimiento.
FR2661809B3 (fr)	1992-05-07	Diffuseur personnel de parfum ou de desodorisant.
FI921864L (fi)	1992-04-24	Substituerade bensoylbenzen-, bifenyl- och 2-oxazolalkansyraderivat som inhibitorer av pla2 och lipoxigenas.
IT9047759A0 (it)	1990-03-15	Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
ES2003063A4 (es)	1988-10-16	Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
GB9025890D0 (en)	1991-01-09	Pharmaceutical compounds
FI953621L (fi)	1996-01-30	Eliprodiilin ja sen enantiomeerien käyttö lääkeaineiden valmistukseen, jotka lääkeaineet ovat käyttökelpoisia syövän vastaisten aineiden aiheuttamien neuropatiatilojen estämiseen
ATE127806T1 (de)	1995-09-15	Antibiotikverbindungen und ihre herstellung.
FI930980A0 (fi)	1993-03-05	Menetelmä fenolin valmistamiseksi bentseenistä suoralla hapetuksella
EP0189877A3 (en)	1987-05-13	Hindered 2-keto-1,4-diazacycloalkane oligomers containing triazine rings or ester groups and compositions stabilized thereby

Legal Events

Date	Code	Title	Description
2017-03-20	MM1K	Lapsed by not paying the annual fees